Which dose of Mounjaro works best for weight loss?

Why does Mounjaro start at 2.5 mg if that is not the most effective dose?

The 2.5 mg pen exists to reduce the chances of nausea and other gastrointestinal side effects that can hit when treatment begins. Mounjaro activates both the GIP and GLP-1 receptors involved in appetite regulation and gastric emptying, and introducing that effect gradually gives the body time to adjust. Think of 2.5 mg as the body's acclimatisation period rather than the treatment itself.

After four weeks at 2.5 mg, the schedule typically moves to 5 mg, then upward in 4-week steps as tolerated. The NHS tirzepatide page describes this titration clearly: dose increases happen approximately monthly, always led by the prescriber's assessment of tolerability and clinical response. Rushing up the ladder is not the goal, nor is stalling unnecessarily at a lower strength.

One practical habit worth building: before each new pen, take a minute to note any side effects you have had in the past week. A brief mental checklist (nausea, bowel changes, energy, appetite) gives your prescriber something concrete to work with at your next review, and it is the kind of detail that shapes a well-timed dose increase.

If you want to understand what the best dose of Mounjaro for weight loss actually looks like, that page works through the question in detail, including how individual responses shape the answer. If you want to understand how 5 mg compares to the starter dose in practice, that page looks at what typically shifts when you make that first step up.

Do higher doses always produce better weight loss results?

The short answer is: generally yes, across populations, but individual responses vary considerably. In the SURMOUNT-1 trial, published in the New England Journal of Medicine, participants on 15 mg lost an average of around 20–21% of body weight over 72 weeks. Those on 10 mg averaged roughly 19%, and the 5 mg group around 15%. So there is a dose-response relationship, but it is not a cliff edge, meaningful weight loss happens at mid-range doses too.

What this means in practice is that some people reach their weight-loss goals at 7.5 mg or 10 mg and have little reason to push further. Others tolerate the full 15 mg well and see the strongest results there. A small number find that side effects at higher doses outweigh the additional benefit, and their prescriber may keep them at a lower maintenance strength. NICE's recommendation for tirzepatide, published in TA1026, notes that continuing treatment is reviewed if less than 5% weight loss has occurred after six months at the highest tolerated dose, that phrase 'highest tolerated' is doing a lot of work. Tolerability is part of the equation.

For a closer look at how the dose picture affects outcomes, the Mounjaro dosage for weight loss page goes into the evidence by strength in more detail.

What factors does a prescriber actually weigh when setting or changing your dose?

Dose decisions are not purely about body weight or BMI. A clinician reviewing your case is looking at several things simultaneously: how much weight you have lost since the last pen, what side effects you have reported, whether you have any conditions that call for more caution, and whether your current dose has had long enough to show its effect.

Gastrointestinal symptoms (nausea, loose stools, reduced appetite) tend to peak in the days after a dose increase and ease within one to two weeks for most people. If they are still disruptive at week three, a prescriber may recommend staying at the current strength for a further four weeks before stepping up. That is not failure; it is the schedule working as intended.

At nume, every repeat order is reviewed by a GPhC-registered Independent Prescriber before it is approved. A real clinician reads your update (your progress, any side effects, your current dose) before the next pen is dispatched. If you are thinking about what that process looks like in context, our about us page describes how the clinical team is structured.

Private treatment costs are a fair consideration too. The Mounjaro price comparison UK page gives an honest account of what private treatment costs across providers, including what is and is not typically included in a headline price.

Is there a point at which staying on a lower dose long-term makes sense?

Yes, and this question comes up more than people expect. Once a target weight or a meaningful plateau has been reached, some patients and their prescribers decide to hold at, say, 10 mg rather than continue climbing. The aim of treatment is the best outcome for the individual, not hitting the maximum dose on the licence.

What gets called the 'maintenance dose' is whichever strength keeps weight stable with tolerable side effects. That concept is worth understanding properly, the maintenance dose explained page covers what it actually means and how it tends to be reached in practice.

Stopping treatment is also a real consideration. Clinical evidence suggests that weight tends to return if treatment is discontinued without the lifestyle changes that supported it, so the conversation about long-term dose management is one worth having with a prescriber early. If you have further questions, our FAQs cover some of the most common ones, or you can start a free consultation and have the conversation directly with one of our prescribers.